PM Aatmanirbhar Swasthya Bharat Yojana
‘Prime Minister AtmanirbharSwasth Bharat Yojana’ (PMASBY) scheme has been announced on 1st February, 2021 in the Budget speech of FY 21-22, with an outlay of about Rs.64,180 Cr over six years (till FY 25-26).This will be in addition to the National Health Mission.
Key features of the scheme
The key features of the Prime Minister AtmanirbharSwasth Bharat Yojana’ (PMASBY) scheme are-
- Over 18,000 rural and over 11,000 urban health and wellness centers will be supported.
- Public health laboratories will be established in all districts.
- Critical care hospitals will be set up in 12 central institutions and 602 districts.
- Strengthens the national centre for disease control, its 5 regional branches as well as 20 metropolitan health surveillance units.
- The scheme will also strengthen 33 existing Public Health Units at the Points of entry, that is at 11 seaports, 32 airports, and 7 land crossings.
Interventions under the scheme
The main interventions under the scheme to be achieved by FY 25-26 are:
- Support for 17,788 rural Health and Wellness Centres in in 10 High Focus States
- Establishing 11,024 urban Health and Wellness Centres in all the States.
- Setting up of Integrated Public Health Labs in all districts and 3382 Block Public Health Units in11 High Focus states;
- Establishing Critical Care Hospital Blocks in 602 districts and 12 Central Institutions;
- Strengthening of the National Centre for Disease Control (NCDC), its 5 regional branches and 20 metropolitan health surveillance units;
- Expansion of the Integrated Health Information Portal to all States/UTs to connect all public health labs;
- Operationalisation of 17 new Public Health Units and strengthening of 33 existing Public Health Units at Points of Entry, that is at 32 Airports, 11 Seaports and 7 landcrossings;
- Setting up of 15 Health Emergency Operation Centres and 2 mobile hospitals; and
- Setting up of a national institution for One Health, a Regional Research Platform for WHO South East Asia Region, 9 Bio-Safety Level III laboratories and 4 regionalNational Institutes for Virology.